BIG
SLDB icon

Brooklyn Investment Group’s Solid Biosciences SLDB Stock Holding History

Brooklyn Investment Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$186K Buy
+25,811
New +$166K 0.01% 1736

Other funds holding SLDB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Brooklyn Investment Group's SLDB Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Solid Biosciences (SLDB) in Q1 2026: 25,811 shares worth $186K. The stake represents 0.01% of the portfolio and ranks #1736 among its holdings.

150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Brooklyn Investment Group held 25,811 shares of Solid Biosciences worth $186K as of Q1 2026.
  • Solid Biosciences was a new Brooklyn Investment Group position in Q1 2026.
  • Solid Biosciences made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1736 holding.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.